Predictive Oncology, Inc. (POAI)
4.95
+0.69
(+16.20%)
USD |
NASDAQ |
Dec 08, 16:00
4.61
-0.34
(-6.87%)
After-Hours: 20:00
Predictive Oncology EPS Diluted (Quarterly): -107.25 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spok Holdings, Inc. | 0.1523 |
| DarioHealth Corp. | -3.052 |
| National Research Corp. | 0.1805 |
| GoodRx Holdings, Inc. | 0.0032 |
| Certara, Inc. | 0.0095 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -77.65M |
| Revenue (Quarterly) | 0.0036M |
| Total Expenses (Quarterly) | 77.65M |
| Enterprise Value | 4.959M |
| Gross Profit Margin (Quarterly) | -4.98K% |
| Profit Margin (Quarterly) | -2.16M% |
| Earnings Yield | -2.34K% |
| Normalized Earnings Yield | -889.08 |